Anchor Sinks $10M Series B, Aileron Lands Deal with Roche, C Change Launches Fund With Vanterra, & More Boston-Area Deals News
Erin Kutz8/25/10Leave a CommentFollow @erkutz
A flurry of tech and life sciences startup financings has kept us busy on the deals news front.
—Andover, MA-based NewRiver, a maker of investor disclosure software, said it will be acquired for $77 million by Lake Success, NY-based Broadridge Financial Solutions (NYSE: BR). NewRiver’s investors include Ironside Ventures, FirstMark Capital, and Lazard Technology Partners.
—PatientsLikeMe, a Cambridge, MA-based provider of social networking platforms for discussion among people with the specific illnesses, raised $8 million of an equity round that could total $30 million.
—Cambridge-based Anchor Therapeutics, formerly Ascent Therapeutics, brought in $10 million in Series B funding from return investors TVM Capital, HealthCare Ventures, and the Novartis Option Fund. The company raised $19 million in its first round of venture funding in 2008.
—Vanu, a Cambridge-based maker of mobile software to power wireless radios, pulled in $2.1 million of a planned $5.2 million round of equity, options, and warrants. The startup raised $32 million in Series B money last year from Charles River Ventures, Norwest Venture Partners, and Tata Capital.
—Enterprise database performance software maker Tokutek, with offices in Lexington, MA and New York City, grabbed $2.8 million of a planned $3.7 million equity-based financing.
—Needham, MA-based Visual IQ, a maker of enterprise marketing analytics software, brought in $3 million from San Francisco’s Fog City Capital. The financing represents the company’s first institutional funding round.
—RatePoint, a Needham maker of online platforms to help businesses manage customer feedback, said it raised a $7 million Series C financing from Prism VentureWorks, .406 Ventures, and Castile Ventures. The deal brings … Next Page »
Erin Kutz is an Associate Editor for Xconomy. You can reach her by e-mail at ekutz@xconomy.com or by phone at (617) 252-0700, or follow her on Twitter at @erkutz.
